Covid-19 crisis: WHO pauses trial of hydroxychloroquine on safety concerns


The World Health Organization has suspended testing the malaria drug hydroxychloroquine in COVID-19 patients due to safety concerns, WHO Director General Tedros Adhanom Ghebreyesus said on Monday. Hydroxycholoroquine has been touted by Donald Trump and others as a possible treatment for the disease caused by the novel coronavirus. The U.

S. President has said he was taking the drug to help prevent infection. “The executive group has implemented a temporary pause of the hydroxychloroquine arm within the Solidarity trial while.

This article is no longer available in our repository.

There could be multiple reasons for this.